Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by YourNadiron Nov 10, 2010 12:14am

160 Views

Post# 17684857

Raising capital?

I have been eyeing a position in HLO for a few weeks. Today's surge was tempered by a general market pullback and it may give me an opportunity to jump in soon.
My only concern is whether Halo will have need to raise money anytime soon because they have little cash in the bank. Is there a likelihood of dilution of their small float in the near future, or are they essentially sitting tight, waiting for a Hudbay buyout?

<< Previous

Bullboard Posts

Next >>

HPQ Silicon updates shareholders on Fumed Silica Reactor developments